Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
1.
Blood ; 143(24): 2490-2503, 2024 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-38493481

RESUMEN

ABSTRACT: Pegylated interferon alfa (pegIFN-α) can induce molecular remissions in patients with JAK2-V617F-positive myeloproliferative neoplasms (MPNs) by targeting long-term hematopoietic stem cells (LT-HSCs). Additional somatic mutations in genes regulating LT-HSC self-renewal, such as DNMT3A, have been reported to have poorer responses to pegIFN-α. We investigated whether DNMT3A loss leads to alterations in JAK2-V617F LT-HSC functions conferring resistance to pegIFN-α treatment in a mouse model of MPN and in hematopoietic progenitors from patients with MPN. Long-term treatment with pegIFN-α normalized blood parameters and reduced splenomegaly and JAK2-V617F chimerism in single-mutant JAK2-V617F (VF) mice. However, pegIFN-α in VF;Dnmt3aΔ/Δ (VF;DmΔ/Δ) mice worsened splenomegaly and failed to reduce JAK2-V617F chimerism. Furthermore, LT-HSCs from VF;DmΔ/Δ mice compared with VF were less prone to accumulate DNA damage and exit dormancy upon pegIFN-α treatment. RNA sequencing showed that IFN-α induced stronger upregulation of inflammatory pathways in LT-HSCs from VF;DmΔ/Δ than from VF mice, indicating that the resistance of VF;DmΔ/Δ LT-HSC was not due to failure in IFN-α signaling. Transplantations of bone marrow from pegIFN-α-treated VF;DmΔ/Δ mice gave rise to more aggressive disease in secondary and tertiary recipients. Liquid cultures of hematopoietic progenitors from patients with MPN with JAK2-V617F and DNMT3A mutation showed increased percentages of JAK2-V617F-positive colonies upon IFN-α exposure, whereas in patients with JAK2-V617F alone, the percentages of JAK2-V617F-positive colonies decreased or remained unchanged. PegIFN-α combined with 5-azacytidine only partially overcame resistance in VF;DmΔ/Δ mice. However, this combination strongly decreased the JAK2-mutant allele burden in mice carrying VF mutation only, showing potential to inflict substantial damage preferentially to the JAK2-mutant clone.


Asunto(s)
ADN (Citosina-5-)-Metiltransferasas , ADN Metiltransferasa 3A , Resistencia a Antineoplásicos , Células Madre Hematopoyéticas , Interferón-alfa , Janus Quinasa 2 , Trastornos Mieloproliferativos , Animales , ADN Metiltransferasa 3A/genética , Janus Quinasa 2/genética , Janus Quinasa 2/metabolismo , ADN (Citosina-5-)-Metiltransferasas/genética , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Interferón-alfa/farmacología , Ratones , Trastornos Mieloproliferativos/genética , Trastornos Mieloproliferativos/patología , Trastornos Mieloproliferativos/tratamiento farmacológico , Trastornos Mieloproliferativos/metabolismo , Humanos , Resistencia a Antineoplásicos/genética , Células Madre Hematopoyéticas/metabolismo , Células Madre Hematopoyéticas/patología , Células Madre Hematopoyéticas/efectos de los fármacos , Autorrenovación de las Células , Ratones Endogámicos C57BL , Polietilenglicoles/farmacología , Proteínas Recombinantes
2.
Blood ; 141(17): 2127-2140, 2023 04 27.
Artículo en Inglés | MEDLINE | ID: mdl-36758212

RESUMEN

JAK 2-V617F mutation causes myeloproliferative neoplasms (MPNs) that can manifest as polycythemia vera (PV), essential thrombocythemia (ET), or primary myelofibrosis. At diagnosis, patients with PV already exhibited iron deficiency, whereas patients with ET had normal iron stores. We examined the influence of iron availability on MPN phenotype in mice expressing JAK2-V617F and in mice expressing JAK2 with an N542-E543del mutation in exon 12 (E12). At baseline, on a control diet, all JAK2-mutant mouse models with a PV-like phenotype displayed iron deficiency, although E12 mice maintained more iron for augmented erythropoiesis than JAK2-V617F mutant mice. In contrast, JAK2-V617F mutant mice with an ET-like phenotype had normal iron stores comparable with that of wild-type (WT) mice. On a low-iron diet, JAK2-mutant mice and WT controls increased platelet production at the expense of erythrocytes. Mice with a PV phenotype responded to parenteral iron injections by decreasing platelet counts and further increasing hemoglobin and hematocrit, whereas no changes were observed in WT controls. Alterations of iron availability primarily affected the premegakaryocyte-erythrocyte progenitors, which constitute the iron-responsive stage of hematopoiesis in JAK2-mutant mice. The orally administered ferroportin inhibitor vamifeport and the minihepcidin PR73 normalized hematocrit and hemoglobin levels in JAK2-V617F and E12 mutant mouse models of PV, suggesting that ferroportin inhibitors and minihepcidins could be used in the treatment for patients with PV.


Asunto(s)
Deficiencias de Hierro , Trastornos Mieloproliferativos , Policitemia Vera , Trombocitemia Esencial , Ratones , Animales , Hierro , Trastornos Mieloproliferativos/tratamiento farmacológico , Trastornos Mieloproliferativos/genética , Trastornos Mieloproliferativos/diagnóstico , Policitemia Vera/genética , Janus Quinasa 2/genética , Trombocitemia Esencial/genética , Mutación , Fenotipo , Hemoglobinas/genética
3.
Blood ; 137(16): 2139-2151, 2021 04 22.
Artículo en Inglés | MEDLINE | ID: mdl-33667305

RESUMEN

We studied a subset of hematopoietic stem cells (HSCs) that are defined by elevated expression of CD41 (CD41hi) and showed bias for differentiation toward megakaryocytes (Mks). Mouse models of myeloproliferative neoplasms (MPNs) expressing JAK2-V617F (VF) displayed increased frequencies and percentages of the CD41hi vs CD41lo HSCs compared with wild-type controls. An increase in CD41hi HSCs that correlated with JAK2-V617F mutant allele burden was also found in bone marrow from patients with MPN. CD41hi HSCs produced a higher number of Mk-colonies of HSCs in single-cell cultures in vitro, but showed reduced long-term reconstitution potential compared with CD41lo HSCs in competitive transplantations in vivo. RNA expression profiling showed an upregulated cell cycle, Myc, and oxidative phosphorylation gene signatures in CD41hi HSCs, whereas CD41lo HSCs showed higher gene expression of interferon and the JAK/STAT and TNFα/NFκB signaling pathways. Higher cell cycle activity and elevated levels of reactive oxygen species were confirmed in CD41hi HSCs by flow cytometry. Expression of Epcr, a marker for quiescent HSCs inversely correlated with expression of CD41 in mice, but did not show such reciprocal expression pattern in patients with MPN. Treatment with interferon-α further increased the frequency and percentage of CD41hi HSCs and reduced the number of JAK2-V617F+ HSCs in mice and patients with MPN. The shift toward the CD41hi subset of HSCs by interferon-α provides a possible mechanism of how interferon-α preferentially targets the JAK2 mutant clone.


Asunto(s)
Interferón-alfa/uso terapéutico , Janus Quinasa 2/genética , Megacariocitos/metabolismo , Trastornos Mieloproliferativos/genética , Animales , Técnicas de Sustitución del Gen , Células Madre Hematopoyéticas/citología , Células Madre Hematopoyéticas/metabolismo , Humanos , Megacariocitos/citología , Ratones , Ratones Transgénicos , Trastornos Mieloproliferativos/tratamiento farmacológico , Glicoproteína IIb de Membrana Plaquetaria/genética , Mutación Puntual/efectos de los fármacos
4.
Blood ; 130(26): 2848-2859, 2017 12 28.
Artículo en Inglés | MEDLINE | ID: mdl-29042365

RESUMEN

Myeloproliferative neoplasms (MPNs) often carry JAK2(V617F), MPL(W515L), or CALR(del52) mutations. Current treatment options for MPNs include cytoreduction by hydroxyurea and JAK1/2 inhibition by ruxolitinib, both of which are not curative. We show here that cell lines expressing JAK2(V617F), MPL(W515L), or CALR(del52) accumulated reactive oxygen species-induced DNA double-strand breaks (DSBs) and were modestly sensitive to poly-ADP-ribose polymerase (PARP) inhibitors olaparib and BMN673. At the same time, primary MPN cell samples from individual patients displayed a high degree of variability in sensitivity to these drugs. Ruxolitinib inhibited 2 major DSB repair mechanisms, BRCA-mediated homologous recombination and DNA-dependent protein kinase-mediated nonhomologous end-joining, and, when combined with olaparib, caused abundant accumulation of toxic DSBs resulting in enhanced elimination of MPN primary cells, including the disease-initiating cells from the majority of patients. Moreover, the combination of BMN673, ruxolitinib, and hydroxyurea was highly effective in vivo against JAK2(V617F)+ murine MPN-like disease and also against JAK2(V617F)+, CALR(del52)+, and MPL(W515L)+ primary MPN xenografts. In conclusion, we postulate that ruxolitinib-induced deficiencies in DSB repair pathways sensitized MPN cells to synthetic lethality triggered by PARP inhibitors.


Asunto(s)
Reparación del ADN/efectos de los fármacos , Trastornos Mieloproliferativos/tratamiento farmacológico , Neoplasias/tratamiento farmacológico , Inhibidores de Poli(ADP-Ribosa) Polimerasas/farmacología , Pirazoles/farmacología , Animales , Calreticulina/genética , Línea Celular , Sinergismo Farmacológico , Xenoinjertos , Humanos , Janus Quinasa 2/genética , Ratones , Trastornos Mieloproliferativos/genética , Neoplasias/genética , Nitrilos , Ftalazinas/farmacología , Piperazinas/farmacología , Pirimidinas , Receptores de Trombopoyetina/genética , Células Tumorales Cultivadas
5.
Blood ; 128(6): 839-51, 2016 08 11.
Artículo en Inglés | MEDLINE | ID: mdl-27288519

RESUMEN

Mutations in JAK2 exon 12 are frequently found in patients with polycythemia vera (PV) that do not carry a JAK2-V617F mutation. The majority of these patients display isolated erythrocytosis. We generated a mouse model that expresses JAK2-N542-E543del, the most frequent JAK2 exon 12 mutation found in PV patients. Mice expressing the human JAK2-N542-E543del (Ex12) showed a strong increase in red blood cell parameters but normal neutrophil and platelet counts, and reduced overall survival. Erythropoiesis was increased in the bone marrow and spleen, with normal megakaryopoiesis and absence of myelofibrosis in histopathology. Erythroid progenitors and precursors were increased in hematopoietic tissues, but the numbers of megakaryocytic precursors were unchanged. Phosphorylation Stat3 and Erk1/2 proteins were increased, and a trend toward increased phospho-Stat5 and phospho-Stat1 was noted. However, Stat1 knock out in Ex12 mice induced no changes in platelet or red cell parameters, indicating that Stat1 does not play a central role in mediating the effects of Ex12 signaling on megakaryopoiesis or erythropoiesis. Ex12 mice showed decreased expression of hepcidin and increased expression of transferrin receptor-1 and erythroferrone, suggesting that the strong erythroid phenotype in Ex12 mutant mice is favored by changes in iron metabolism that optimize iron availability to allow maximal production of red cells.


Asunto(s)
Eritropoyesis , Janus Quinasa 2/genética , Mutación , Policitemia/genética , Animales , Secuencia de Bases , Eritrocitos/patología , Exones , Hierro/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Policitemia/metabolismo , Policitemia/fisiopatología
6.
Blood ; 125(13): 2131-40, 2015 Mar 26.
Artículo en Inglés | MEDLINE | ID: mdl-25595737

RESUMEN

The acquired somatic JAK2-V617F mutation is present in >80% of patients with myeloproliferative neoplasms (MPNs). Stat3 plays a role in hematopoietic homeostasis and might influence the JAK2-V617F-driven MPN phenotype. We crossed our transgenic SclCre;V617F mice with a conditional Stat3 knockout strain and performed bone marrow transplantations into lethally irradiated recipient mice. The deletion of Stat3 increased the platelet numbers in SclCre;V617F;Stat3(fl/fl) mice compared with SclCre;V617F;Stat3(fl/+) or SclCre;V617F;Stat3(+/+) mice. Stat3 deletion also normalized JAK2-V617F-induced neutrophilia. Megakaryocyte progenitors were elevated, especially in the spleen, and a slight increase in myelofibrosis was noted. We observed increased mRNA expression levels of Stat1 and Stat1 target genes and augmented phosphorylation of Stat1 protein in bone marrow and spleen of JAK2-V617F mice after Stat3 deletion. The survival of Stat3-deficient mice expressing JAK2-V617F was reduced. Inflammatory bowel disease, previously associated with shortened survival of Stat3-deficient mice, was less prominent in the bone marrow transplantation setting, possibly by limiting deletion of Stat3 to hematopoietic tissues only. In conclusion, deletion of Stat3 in hematopoietic cells from JAK2-V617F mice did not ameliorate the course of MPN, but rather enhanced thrombocytosis and shortened the overall survival.


Asunto(s)
Neoplasias de la Médula Ósea/mortalidad , Células Madre Hematopoyéticas/metabolismo , Janus Quinasa 2/genética , Trastornos Mieloproliferativos/mortalidad , Factor de Transcripción STAT3/genética , Trombocitosis/genética , Sustitución de Aminoácidos , Animales , Médula Ósea/metabolismo , Neoplasias de la Médula Ósea/genética , Neoplasias de la Médula Ósea/metabolismo , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Eliminación de Gen , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Trastornos Mieloproliferativos/genética , Trastornos Mieloproliferativos/metabolismo , Fenilalanina/genética , Factor de Transcripción STAT3/metabolismo , Valina/genética
7.
Blood ; 123(25): 3943-50, 2014 Jun 19.
Artículo en Inglés | MEDLINE | ID: mdl-24820309

RESUMEN

The interferon-γ (IFNγ)/signal transducer and activator of transcription 1 (Stat1) pathway shows higher activity in patients with essential thrombocythemia (ET) than in polycythemia vera (PV) and was proposed to be promoting the ET phenotype. We explored the phenotypic consequences of Stat1 deficiency on the effects of Janus kinase 2 (JAK2)-V617F in vivo by crossing mice expressing JAK2-V617F with Stat1 knockout mice. JAK2-V617F;Stat1(-/-) double transgenic mice showed higher red cell parameters and lower platelet counts compared with JAK2-V617F;Stat1(+/+) mice. Bone marrow transplantation reproduced these phenotypic changes in wild-type recipients, demonstrating that the effect of Stat1 is cell-intrinsic and does not require a Stat1-deficient microenvironment. Deletion of Stat1 increased burst-forming unit-erythroid and reduced colony-forming unit-megakaryocyte colony formation driven by JAK2-V617F, but was not sufficient to completely normalize the platelet count. Gata1, a key regulator of megakaryopoiesis and erythropoiesis, was decreased in Stat1-deficient platelets. V617F transgenic mice with thrombocytosis had higher serum levels of IFNγ than normal controls and patients with ET showed higher IFNγ serum levels than patients with PV. Together, these results support the concept that activating Stat1 in the presence of JAK2-V617F, for example, through IFNγ, constrains erythroid differentiation and promotes megakaryocytic development, resulting in ET phenotype.


Asunto(s)
Neoplasias de la Médula Ósea/genética , Eritropoyesis/genética , Janus Quinasa 2/genética , Mutación , Factor de Transcripción STAT1/genética , Trombopoyesis/genética , Animales , Western Blotting , Neoplasias de la Médula Ósea/sangre , Neoplasias de la Médula Ósea/metabolismo , Trasplante de Médula Ósea/métodos , Modelos Animales de Enfermedad , Femenino , Citometría de Flujo , Células Madre Hematopoyéticas/citología , Células Madre Hematopoyéticas/metabolismo , Humanos , Interferón gamma/sangre , Janus Quinasa 2/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Policitemia Vera/sangre , Policitemia Vera/genética , Policitemia Vera/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor de Transcripción STAT1/metabolismo , Trombocitemia Esencial/sangre , Trombocitemia Esencial/genética , Trombocitemia Esencial/metabolismo
8.
Blood ; 121(7): 1188-99, 2013 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-23264594

RESUMEN

To establish a preclinical animal model for testing drugs with potential effects on myeloproliferative neoplasms (MPNs), we first performed a detailed phenotypic characterization of Cre-inducible transgenic JAK2-V617F mice. Deleting the conditional mouse Jak2-knockout alleles increased erythropoiesis and accentuated the polycythemia vera phenotype, but did not alter platelet or granulocyte levels. In a transplantation assay, JAK2-V617F(+) BM cells had an advantage over wild-type competitor cells. Using this competitive repopulation assay, we compared the effects of INC424 (ruxolitinib), a dual Jak1/Jak2 inhibitor, and hydroxyurea (HU). HU led to weight loss, but did not reduce spleen weight. The hematologic parameters were lowered and a slight decrease of the mutant allele burden was noted. INC424 had little effect on body weight, but strongly decreased spleen size and rapidly normalized RBC and neutrophil parameters. No significant decrease in the mutant allele burden was observed. INC424 reduced the phospho-Stat5 levels, whereas HU strongly increased phospho-Stat5, most likely because of the elevated erythropoietin levels in response to the HU-induced anemia. This compensatory increase in JAK/STAT signaling may counteract the beneficial effects of cytoreduction at higher doses of HU and represents an adverse effect that should be avoided.


Asunto(s)
Hidroxiurea/farmacología , Janus Quinasa 2/genética , Policitemia Vera/tratamiento farmacológico , Policitemia Vera/genética , Pirazoles/farmacología , Alelos , Sustitución de Aminoácidos , Animales , Trasplante de Médula Ósea , Modelos Animales de Enfermedad , Femenino , Hematopoyesis/efectos de los fármacos , Hematopoyesis/genética , Janus Quinasa 2/antagonistas & inhibidores , Janus Quinasa 2/deficiencia , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Mutación , Nitrilos , Fenotipo , Policitemia Vera/metabolismo , Policitemia Vera/patología , Pirimidinas , Factor de Transcripción STAT5/metabolismo , Transducción de Señal/efectos de los fármacos
9.
Nat Commun ; 9(1): 1431, 2018 04 12.
Artículo en Inglés | MEDLINE | ID: mdl-29650953

RESUMEN

Heat shock protein 27 (HSP27/HSPB1) is a stress-inducible chaperone that facilitates cancer development by its proliferative and anti-apoptotic functions. The OGX-427 antisense oligonucleotide against HSP27 has been reported to be beneficial against idiopathic pulmonary fibrosis. Here we show that OGX-427 is effective in two murine models of thrombopoietin- and JAKV617F-induced myelofibrosis. OGX-427 limits disease progression and is associated with a reduction in spleen weight, in megakaryocyte expansion and, for the JAKV617F model, in fibrosis. HSP27 regulates the proliferation of JAK2V617F-positive cells and interacts directly with JAK2/STAT5. We also show that its expression is increased in both CD34+ circulating progenitors and in the serum of patients with JAK2-dependent myeloproliferative neoplasms with fibrosis. Our data suggest that HSP27 plays a key role in the pathophysiology of myelofibrosis and represents a new potential therapeutic target for patients with myeloproliferative neoplasms.


Asunto(s)
Proteínas de Choque Térmico HSP27/genética , Janus Quinasa 2/genética , Oligonucleótidos/farmacología , Mielofibrosis Primaria/tratamiento farmacológico , Mielofibrosis Primaria/genética , Factor de Transcripción STAT5/genética , Animales , Células de la Médula Ósea/inmunología , Células de la Médula Ósea/patología , Trasplante de Médula Ósea , Línea Celular Tumoral , Modelos Animales de Enfermedad , Femenino , Células HEK293 , Proteínas de Choque Térmico HSP27/inmunología , Humanos , Janus Quinasa 2/inmunología , Células K562 , Leucocitos/efectos de los fármacos , Leucocitos/inmunología , Leucocitos/patología , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Terapia Molecular Dirigida , Mutación , Mielofibrosis Primaria/inmunología , Mielofibrosis Primaria/patología , Factor de Transcripción STAT5/inmunología , Trombopoyetina/genética , Trombopoyetina/inmunología , Transducción Genética , Irradiación Corporal Total
10.
Biochim Biophys Acta ; 1763(1): 18-24, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16377004

RESUMEN

Inositol 1,4,5-trisphosphate (IP3) receptors are calcium-releasing channels localized on the sarcoplasmic reticulum. IP3 receptors mediate the calcium mobilizing effect of a wide range of hormones, cytokines, and neurotransmitters and play an important role in variety of cell functions. The aim of this work was to study, how partial depletion of catecholamines affects the gene expression and protein levels of the type 1 IP3 receptors in rat heart. The type 1 IP3 receptor mRNA levels were studied in the left cardiac atrium and ventricle of rats treated with 6-hydroxydopamine (6-OHDA) in control and stressed conditions. The 6-OHDA produces anatomical and functional denervation resulting in decreased levels of noradrenaline and adrenaline. We also used corticoliberin (CRH) knockout mice, where secretion of adrenaline is significantly suppressed. Administration of 6-OHDA significantly decreases mRNA levels of the type 1 IP3 receptor in both, the left atrium and the left ventricle, while the gene expression of the sarcoplasmic reticular Ca2+-ATPase (SERCA 2) was unaffected. CRH knockout mice possess markedly lower levels of the type 1 IP3 receptor mRNA compared to wild-type mice in both, control and stressed conditions. These data point to the adrenergic modulation of the type 1 IP3 receptors in the rat hearts.


Asunto(s)
Canales de Calcio/metabolismo , Epinefrina/metabolismo , Miocardio/metabolismo , Norepinefrina/metabolismo , Receptores Citoplasmáticos y Nucleares/metabolismo , Animales , Canales de Calcio/genética , Epinefrina/sangre , Atrios Cardíacos/efectos de los fármacos , Ventrículos Cardíacos/efectos de los fármacos , Receptores de Inositol 1,4,5-Trifosfato , Masculino , Ratones , Ratones Noqueados , Norepinefrina/sangre , Oxidopamina/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores Citoplasmáticos y Nucleares/genética
11.
J Mol Neurosci ; 30(1-2): 69-70, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17192632

RESUMEN

In the last decade, progress in gene disruption technology has allowed the study of the effects of the single-gene knockout (KO) on different molecules involved in the signaling cascade activated via muscarinic receptors. Many KO mice targeting muscarinic receptors have been developed, that is, all (M1-M5) muscarinic receptor KO mice (Wess, 2003) and acetylcholinesterase (AChE) KO mice(Xie et al., 2000). Recently, we have shown that these (AChE-/-) mice not only reveal changes in the number of muscarinic receptors in the heart, lung, cortex, and cerebellum but also in the number of adrenoceptors (Teplicky et al., 2004). Next, we studied whether the disruption of corticotropin-releasing hormone (CRH) or c-Fos could affect the properties of muscarinic receptors and adrenoceptors in the lungs and hearts of mice. The effects of immobilization stress in CRH KO animals were also studied.


Asunto(s)
Hormona Liberadora de Corticotropina/fisiología , Genes fos , Receptores Adrenérgicos/fisiología , Receptores Muscarínicos/fisiología , Animales , Hormona Liberadora de Corticotropina/deficiencia , Hormona Liberadora de Corticotropina/genética , Ratones , Ratones Noqueados , Restricción Física , Estrés Psicológico/fisiopatología
12.
J Exp Med ; 213(8): 1479-96, 2016 07 25.
Artículo en Inglés | MEDLINE | ID: mdl-27401344

RESUMEN

Myeloproliferative neoplasm (MPN) patients frequently show co-occurrence of JAK2-V617F and mutations in epigenetic regulator genes, including EZH2 In this study, we show that JAK2-V617F and loss of Ezh2 in hematopoietic cells contribute synergistically to the development of MPN. The MPN phenotype induced by JAK2-V617F was accentuated in JAK2-V617F;Ezh2(-/-) mice, resulting in very high platelet and neutrophil counts, more advanced myelofibrosis, and reduced survival. These mice also displayed expansion of the stem cell and progenitor cell compartments and a shift of differentiation toward megakaryopoiesis at the expense of erythropoiesis. Single cell limiting dilution transplantation with bone marrow from JAK2-V617F;Ezh2(+/-) mice showed increased reconstitution and MPN disease initiation potential compared with JAK2-V617F alone. RNA sequencing in Ezh2-deficient hematopoietic stem cells (HSCs) and megakaryocytic erythroid progenitors identified highly up-regulated genes, including Lin28b and Hmga2, and chromatin immunoprecipitation (ChIP)-quantitative PCR (qPCR) analysis of their promoters revealed decreased H3K27me3 deposition. Forced expression of Hmga2 resulted in increased chimerism and platelet counts in recipients of retrovirally transduced HSCs. JAK2-V617F-expressing mice treated with an Ezh2 inhibitor showed higher platelet counts than vehicle controls. Our data support the proposed tumor suppressor function of EZH2 in patients with MPN and call for caution when considering using Ezh2 inhibitors in MPN.


Asunto(s)
Proteína Potenciadora del Homólogo Zeste 2/deficiencia , Neoplasias Hematológicas , Janus Quinasa 2 , Mutación Missense , Trastornos Mieloproliferativos , Proteínas Supresoras de Tumor/deficiencia , Sustitución de Aminoácidos , Animales , Neoplasias Hematológicas/genética , Neoplasias Hematológicas/metabolismo , Neoplasias Hematológicas/patología , Janus Quinasa 2/genética , Janus Quinasa 2/metabolismo , Ratones , Ratones Mutantes , Trastornos Mieloproliferativos/genética , Trastornos Mieloproliferativos/metabolismo , Trastornos Mieloproliferativos/patología
13.
Alcohol ; 37(3): 157-66, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16713504

RESUMEN

Numerous reports document altered drinking behavior following acute stressors but few describe physiological responses to acute stress of chronic ethanol consuming subjects. We tested rats' responses to 120-min foot restraint immobilization (Immo) after 1 week of liquid diet containing 5% wt/vol ethanol (ethanol-fed). Controls consumed isocaloric liquid diet ad libitum (adlib-fed) or in amounts equal to that of ethanol-fed subjects on the previous day (pair-fed). Each rat was implanted with a tail artery cannula on day 7 to allow remote blood collection before and during Immo on day 8. Plasma epinephrine (Epi); norepinephrine (NE); corticosterone (Cort); prolactin (PRL); adrenomedullary gene expression of catecholamine biosynthetic enzymes tyrosine hydroxylase (TH), dopamine beta-hydroxylase (DBH), and phenylethanolamine-N-methyl transferase (PNMT); and TH protein levels were measured. Ethanol-fed rats had two to threefold higher basal plasma Epi and NE and tended to have increased Cort compared to adlib-fed or pair-fed rats. Immo increased Epi and NE in ethanol-fed rats more than twofold above those observed in controls, and also increased Cort more in ethanol-fed than in control rats. PRL was marginally affected. Ethanol potentiated the normal immobilization-induced increase in adrenomedullary TH, DBH, and PNMT messenger RNA (mRNA). TH protein increased only in ethanol-fed rats. Increased plasma catecholamine levels, adrenomedullary gene expression, and TH protein concentration in nonimmobilized ethanol-fed rats strongly suggest that ethanol consumption was itself a stressor, which potentiated the subsequent response to acute Immo. Moreover, the observed interaction of ethanol and stress on plasma catecholamine levels illustrates the importance of minimizing additional stressful stimuli when investigating ethanol's physiological effects.


Asunto(s)
Médula Suprarrenal/efectos de los fármacos , Consumo de Bebidas Alcohólicas/sangre , Corticosterona/sangre , Epinefrina/sangre , Regulación de la Expresión Génica/efectos de los fármacos , Norepinefrina/sangre , Prolactina/sangre , ARN Mensajero/genética , Estrés Psicológico/sangre , Médula Suprarrenal/fisiopatología , Consumo de Bebidas Alcohólicas/efectos adversos , Animales , Nivel de Alerta/efectos de los fármacos , Nivel de Alerta/genética , Nivel de Alerta/fisiología , Dopamina beta-Hidroxilasa/genética , Regulación de la Expresión Génica/genética , Masculino , Feniletanolamina N-Metiltransferasa/genética , Ratas , Ratas Sprague-Dawley , Estrés Psicológico/complicaciones , Tirosina 3-Monooxigenasa/genética
14.
Thromb Haemost ; 113(2): 414-25, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25298269

RESUMEN

We studied haemostasis in two mouse models with thrombocytosis caused by different pathogenic mechanisms. In one strain (Yall;Mpl-/-) thrombocytosis is driven by a misbalance between thrombopoietin and its receptor, whereas in the other strain, thrombocytosis is caused by expressing a human JAK2-V617F transgene (FF1) that depends on activation by Cre-recombinase (VavCre;FF1, MxCre;FF1). Thrombotic responses were increased following some, but not all types of challenges. In a vaso-occlusive thrombotic model following collagen-adrenaline injection we found increased mortality in both strains. Arterial thrombosis, examined after ferric chloride-induced carotid injury, was accelerated but with little impact on maximal thrombus size. In a vena cava stasis model, clots were of similar size as in wild-type controls, but exhibited a different composition with a higher platelet to fibrin ratio. Both thrombocytosis strains displayed increased haemorrhagic tendency in a tail bleeding assay. Yall;Mpl and VavCre;FF1 displayed a lower proportion of the more reactive high-molecular-weight forms of von Willebrand factor in their plasma, mimicking essential thrombocythaemia with very high platelet counts. Bleeding could not be explained by clear defects in platelet activation, which were normal or only weakly decreased. In conclusion, these models of thrombocytosis recapitulate several features of the haemorrhagic and thrombotic diatheses in ET and PV demonstrating potentials but also some limitations to study these major complications.


Asunto(s)
Hemorragia/sangre , Trombocitosis/sangre , Animales , Arterias/patología , Coagulación Sanguínea , Plaquetas/metabolismo , Arterias Carótidas/fisiopatología , Colágeno/metabolismo , Modelos Animales de Enfermedad , Femenino , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Modelos de Riesgos Proporcionales , Receptores de Trombopoyetina/metabolismo , Tromboembolia/fisiopatología , Trombopoyetina/metabolismo , Trombosis/fisiopatología , Transgenes
15.
Ann N Y Acad Sci ; 1018: 398-404, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15240395

RESUMEN

The aim of the present study was to reveal stress-type dependent differences in hindbrain catecholaminergic (CA) cells and parabrachial nuclei (PBN) in the wild-type mouse. Neuronal activities were evaluated based on the incidence of Fos-labeling analyzed 60 min after injection of hypertonic saline (HS; 400 microL, 1.5 M, i.p.) or 120 min of immobilization (IMO) stress. The phenotypic nature of neurons was identified by costaining of Fos with either tyrosine hydroxylase (TH) or the neuropeptide Y (NPY) antibody. Generally, HS elicited broader Fos-staining than IMO. In comparison with IMO, HS induced more extensive Fos activation in the nucleus tractus solitarii-area postrema complex, and in TH- and NPY-positive cells in the A1 and C1 areas. Locus coeruleus (LC) cells displayed similar Fos activation after HS and IMO, and both stimuli also evoked evident TH-Fos colocalizations. Both stimuli also induced TH-Fos costainings in the A5 area. In contrast, IMO failed to activate PBN cells. The data indicate that the activity of TH and NPY hindbrain neurons responds differently to HS and IMO stress, supporting the notion that different stressors have different effects on the activity of autonomic centers.


Asunto(s)
Encéfalo/metabolismo , Inmovilización , Neuropéptido Y/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Tirosina 3-Monooxigenasa/metabolismo , Animales , Encéfalo/enzimología , Femenino , Inmunohistoquímica , Ratones , Ratones Endogámicos C57BL , Concentración Osmolar
16.
Ann N Y Acad Sci ; 1018: 124-30, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15240360

RESUMEN

Catecholamines (CAs) are significantly involved in the regulation of homeostasis of the organism at rest and especially during stressful situations. Stress induces increases in plasma CA (epinephrine and norepinephrine) levels and prolactin (PRL) release from the adenopituitary. We have recently observed that salsolinol, which is produced by the neuro-intermediate lobe of the pituitary gland and by the hypothalamus, can selectively release PRL. Salsolinol is therefore considered to be a putative endogenous PRL-releasing factor. Based on the similarity of CA and PRL responses to stressors, we investigated whether salsolinol plays a role in the regulation of plasma CA levels at rest and of CA release induced by immobilization stress (IMO). Salsolinol did not affect CA baseline levels; however, it did inhibit IMO-induced CA release. Thus, the present study shows for the first time that salsolinol is not only a PRL-releasing factor but is also a potent inhibitor of stress-induced release of epinephrine and norepinephrine.


Asunto(s)
Catecolaminas/sangre , Inmovilización , Isoquinolinas/farmacología , Estrés Fisiológico/sangre , Animales , Isoquinolinas/administración & dosificación , Masculino , Ratas
17.
Ann N Y Acad Sci ; 1018: 173-82, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15240366

RESUMEN

Most alcohol researchers do not address the effects of intoxication on the sympatho-adrenomedullary system response to stressful situations. We previously determined that rats consuming nearly 9 g ethanol (EtOH) per kg body weight per day in liquid diet form for 1 week increased adrenal gene expression of enzymes for catecholamine synthesis that was further elevated by acute IMMO. We hypothesized that the response to chronic mild stressors would also be altered after consumption of lower concentrations of EtOH in drinking water. Two experiments were conducted: 10% w/v for 4 weeks or 6% w/v for 7 weeks +/- wire mesh restraint (WMR). These were compared with ad libitum (adlib) and pair-fed control rats. Adrenal gene expression of catecholamine synthesizing enzymes was assayed. Tyrosine hydroxylase gene expression was elevated 80% to 90% by alcohol consumption in both experiments (P < 0.001) compared with adlib control rats. Dopamine betab-hydroxylase and phenylethanolamine-N-methyl transferase gene expressions were unaffected by 10% alcohol (P > 0.05) but were increased by 6% alcohol (P < 0.01). WMR decreased already elevated gene expression of all three enzymes. Pair feeding to 6% EtOH drinkers also increased gene expression for the three enzymes but was decreased by WMR, although not to levels of adlib rats. Increased gene expression for adrenal synthesis of catecholamines in response to repeated alcohol consumption increases the likelihood that the subject can respond physiologically to acute or chronic stress. This may have life-saving consequences in humans and in animals known to consume fermented materials and may contribute to increased aggressive behavior.


Asunto(s)
Médula Suprarrenal/efectos de los fármacos , Etanol/farmacología , Estrés Fisiológico/fisiopatología , Médula Suprarrenal/fisiopatología , Animales , Regulación de la Expresión Génica/efectos de los fármacos , Masculino , Ratas , Ratas Sprague-Dawley
18.
Ann N Y Acad Sci ; 1018: 339-44, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15240388

RESUMEN

Stress is one of the major contributors to the development of cardiovascular disorders and psychiatric illnesses. Immobilization stress belongs to severe stressors and is known to activate several calcium transport systems. The aim of this work was to determine whether repeated immobilization stress changes mRNA and protein levels of the type 1 and 2 inositol-1,4,5-trisphosphate (IP(3)) receptors in cardiac tissue. Rats were immobilized for 7 days, 2 h daily. After repeated immobilization, increased numbers of collagen fibers were accumulated in the heart atria compared to hearts of the control group of rats. Gene expression was determined after reverse transcription and subsequent real-time polymerase chain reaction, using SYBR Green fluorescent dye. Protein levels were determined by Western blot and hybridization with the primary antibody against IP(3) receptors. Contrary to single immobilization, repeated immobilization decreased a gene expression of the type 1 and 2 IP(3) receptors, and also protein levels of the IP(3) receptors. Although the physiologic relevance of our observations remains to be elucidated, we propose that the decrease in IP(3) receptors may have an impact on the development of the pathophysiologic changes in the heart.


Asunto(s)
Canales de Calcio/metabolismo , Inmovilización , Miocardio/metabolismo , ARN Mensajero/metabolismo , Receptores Citoplasmáticos y Nucleares/metabolismo , Estrés Fisiológico/metabolismo , Animales , Secuencia de Bases , Western Blotting , Canales de Calcio/genética , Cartilla de ADN , Receptores de Inositol 1,4,5-Trifosfato , Masculino , Miocardio/ultraestructura , Reacción en Cadena de la Polimerasa , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Receptores Citoplasmáticos y Nucleares/genética , Estrés Fisiológico/genética
19.
Ann N Y Acad Sci ; 1018: 405-17, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15240396

RESUMEN

Recently we have described the existence of phenylethanolamine N-methyltransferase (PNMT) mRNA in the heart of adult rats. In this study, we report the first data on distribution of the PNMT protein in rat hearts, which follows the distribution of PNMT mRNA (high levels in the atria and low levels in ventricles). The main aim of this study was to determine the localization of the PNMT mRNA in the heart and to examine whether gene expression of this enzyme is affected by immobilization (IMO) stress in a time-dependent manner. PNMT mRNA levels were detected in all seven studied parts of the heart (atria without and with intramural ganglion cells, ventricles, and septum), with the highest levels in the left atrium and its ganglionic part. Both Southern blot and sequencing verified the specificity of PNMT detected by RT-PCR. Single IMO for 2-h increased gene expression of PNMT, as determined by both RT-PCR and Real-Time PCR in the right and left atria. Surprisingly, the ganglionic parts of the atria did not respond to stress stimulation. Peak levels of PNMT mRNA were found in the 3-h interval after the IMO terminated, and also 24 h after the first or sixth IMO. Expression of aromatic L-amino acids decarboxylase and dopamine-beta-hydroxylase has also been detected in the heart of control and stressed rats. In the atria, the effect of stress is clearly modulated by glucocorticoids, since in mice with corticotrophin-releasing hormone knocked out gene the immobilization-induced increase in the PNMT mRNA levels seen in wild-type animals was abolished. Thus, our data have shown that gene expression of the PNMT is localized, not predominantly in cardiac ganglion cells, but in a wide range in atrial cardiomyocytes. Mechanism responsible for the regulation of stress-induced increase of PNMT gene expression in cardiac atria is clearly dependent on the presence of glucocorticoids.


Asunto(s)
Regulación Enzimológica de la Expresión Génica/fisiología , Miocardio/enzimología , Feniletanolamina N-Metiltransferasa/genética , Estrés Fisiológico/fisiopatología , Animales , Masculino , Ratones , Ratones Noqueados , Feniletanolamina N-Metiltransferasa/metabolismo , Reacción en Cadena de la Polimerasa , ARN Mensajero/genética , Ratas , Ratas Sprague-Dawley , Estrés Fisiológico/enzimología
20.
J Exp Med ; 211(11): 2213-30, 2014 Oct 20.
Artículo en Inglés | MEDLINE | ID: mdl-25288396

RESUMEN

The majority of patients with myeloproliferative neoplasms (MPNs) carry a somatic JAK2-V617F mutation. Because additional mutations can precede JAK2-V617F, it is questioned whether JAK2-V617F alone can initiate MPN. Several mouse models have demonstrated that JAK2-V617F can cause MPN; however, in all these models disease was polyclonal. Conversely, cancer initiates at the single cell level, but attempts to recapitulate single-cell disease initiation in mice have thus far failed. We demonstrate by limiting dilution and single-cell transplantations that MPN disease, manifesting either as erythrocytosis or thrombocytosis, can be initiated clonally from a single cell carrying JAK2-V617F. However, only a subset of mice reconstituted from single hematopoietic stem cells (HSCs) displayed MPN phenotype. Expression of JAK2-V617F in HSCs promoted cell division and increased DNA damage. Higher JAK2-V617F expression correlated with a short-term HSC signature and increased myeloid bias in single-cell gene expression analyses. Lower JAK2-V617F expression in progenitor and stem cells was associated with the capacity to stably engraft in secondary recipients. Furthermore, long-term repopulating capacity was also present in a compartment with intermediate expression levels of lineage markers. Our studies demonstrate that MPN can be initiated from a single HSC and illustrate that JAK2-V617F has complex effects on HSC biology.


Asunto(s)
Transformación Celular Neoplásica/genética , Células Madre Hematopoyéticas/metabolismo , Janus Quinasa 2/genética , Mutación , Trastornos Mieloproliferativos/genética , Alelos , Animales , Antígenos Ly/metabolismo , Antígenos de Superficie/metabolismo , Biomarcadores/metabolismo , Trasplante de Médula Ósea , Ciclo Celular/genética , Linaje de la Célula/genética , Análisis por Conglomerados , Daño del ADN , Femenino , Expresión Génica , Perfilación de la Expresión Génica , Células Madre Hematopoyéticas/patología , Inmunofenotipificación , Proteínas de la Membrana/metabolismo , Ratones , Ratones Noqueados , Fenotipo , Proteínas Proto-Oncogénicas c-kit/metabolismo , Quimera por Trasplante
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA